Effects of High Blood Flow and High Pre-Dilution Replacement Fluid Rates on Small Solute Clearances in Hemofiltration

被引:9
作者
Gashti, Casey N. [1 ]
Rodby, Roger A. [1 ]
Huang, Zhongping [2 ]
Gao, Dayong [3 ]
Zhang, Weiming [4 ]
机构
[1] Rush Univ, Nephrol Sect, Med Ctr, Chicago, IL 60612 USA
[2] Widener Univ, Dept Mech Engn, Chester, PA 19013 USA
[3] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
[4] Shanghai Jiao Tong Univ, Div Renal, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China
关键词
Pre-dilution; Hemofiltration; Clearance; CONTINUOUS VENOVENOUS HEMOFILTRATION; POST-DILUTION; THERAPY;
D O I
10.1159/000328740
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: In pre-dilution hemofiltration (HF), solute clearance is less than the HF rate. While the amount of this loss is predictable, it has not been validated in high-volume HF associated with high blood flow rates. Methods: Using isovolemic pre-dilution HF, we studied small solute clearances using combinations of blood flow (Q(B); 150, 250, 350, 450 ml/min) and replacement fluid (RF) flow (Q(RF); 2, 4, 6 l/h) to determine clearance losses we entitled 'measured efficiency' (E-M). E-M was compared to predicted efficiency (E-P) = (Q(B)/Q(B) + Q(RF)). Results: Pre-dilution produced E-M values of 61-93%. Increases in Q(B) for any Q(RF) and decreases in Q(RF) for any Q(B) increased E-M over a wide range of Q(B) and Q(RF). E-P was equivalent to E-M. Conclusion: In high-volume pre-dilution HF, E-P can be used to determine E-M across a broad range of Q(B) and Q(RF) values. Higher Q(RF) requires higher Q(B) to minimize the attenuating effects of pre-dilution on clearance. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:266 / 270
页数:5
相关论文
共 13 条
[1]   Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates [J].
Brunet, S ;
Leblanc, M ;
Geadah, D ;
Parent, D ;
Courteau, S ;
Cardinal, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (03) :486-492
[2]   UREA MOVEMENT ACROSS ERYTHROCYTE-MEMBRANE DURING ARTIFICIAL-KIDNEY TREATMENT [J].
CHEUNG, AK ;
ALFORD, MF ;
WILSON, MM ;
LEYPOLDT, JK ;
HENDERSON, LW .
KIDNEY INTERNATIONAL, 1983, 23 (06) :866-869
[3]   Accelerated venovenous hemofiltration: Early technical and clinical experience [J].
Gashti, Casey N. ;
Salcedo, Susana ;
Robinson, Virginia ;
Rodby, Roger A. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (05) :804-810
[4]   Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration [J].
Huang, Z. ;
Letteri, J. J. ;
Clark, W. R. ;
Zhang, W. ;
Gao, D. ;
Ronco, C. .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (02) :124-132
[5]   Dialysis dosing in critically ill patients with acute kidney injury [J].
Humes, H. David ;
Ding, Feng ;
Song, Joon Ho .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (04) :649-652
[6]   Dialysis Results of RENAL-what is the optimal CRRT target dose? [J].
Kellum, John A. ;
Ronco, Claudio .
NATURE REVIEWS NEPHROLOGY, 2010, 6 (04) :191-192
[7]   Continuous Venovenous Hemofiltration with or without predilution regional citrate anticoagulation: A prospective study [J].
Nurmohamed, S. Azam ;
Vervloet, Marc G. ;
Girbes, Armand R. J. ;
Ter Wee, Pieter M. ;
Groeneveld, A. B. Johan .
BLOOD PURIFICATION, 2007, 25 (04) :316-323
[8]   Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically Ill [J].
Oudemans-van Straaten, Heleen M. .
BLOOD PURIFICATION, 2010, 29 (02) :191-196
[9]   Dialyzer-dependent changes in solute and water permeability with bleach reprocessing [J].
Scott, MK ;
Mueller, BA ;
Sowinski, KM ;
Clark, WR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (01) :87-96
[10]   Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters [J].
Troyanov, S ;
Cardinal, J ;
Geadah, D ;
Parent, D ;
Courteau, S ;
Caron, S ;
Leblanc, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (05) :961-966